|
TUFT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.664900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.984500E-03 |
| Normal-vs-Stage2 |
3.958800E-03 |
| Normal-vs-Stage3 |
1.178530E-03 |
| Normal-vs-Stage4 |
7.810500E-04 |
| Stage1-vs-Stage2 |
4.999800E-01 |
| Stage1-vs-Stage3 |
4.842900E-03 |
| Stage1-vs-Stage4 |
4.424200E-03 |
| Stage2-vs-Stage3 |
1.882390E-01 |
| Stage2-vs-Stage4 |
9.636000E-02 |
| Stage3-vs-Stage4 |
5.347400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.557300E-03 |
| Normal-vs-AfricanAmerican |
4.700300E-03 |
| Normal-vs-Asian |
7.420400E-03 |
| Caucasian-vs-AfricanAmerican |
6.396000E-01 |
| Caucasian-vs-Asian |
7.396600E-01 |
| AfricanAmerican-vs-Asian |
8.902000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.323700E-03 |
| Normal-vs-Female |
9.558100E-03 |
| Male-vs-Female |
9.159600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.264700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.758000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.296100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.693900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.195800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.021000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.128200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.104800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.335450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.126430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.397000E-01 |
| Normal-vs-Grade 2 |
3.958000E-03 |
| Normal-vs-Grade 3 |
3.722500E-03 |
| Normal-vs-Grade 4 |
2.037600E-04 |
| Grade 1-vs-Grade 2 |
6.983800E-03 |
| Grade 1-vs-Grade 3 |
2.445900E-02 |
| Grade 1-vs-Grade 4 |
1.54220000003757E-06 |
| Grade 2-vs-Grade 3 |
8.657200E-01 |
| Grade 2-vs-Grade 4 |
2.11829999999802E-05 |
| Grade 3-vs-Grade 4 |
6.44149999999843E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.829720E-02 |
| Normal-vs-ccB subtype |
3.387000E-04 |
| ccA subtype-vs-ccB subtype |
3.3092417695002E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.978200E-03 |
| Normal-vs-N1 |
1.697950E-03 |
| N0-vs-N1 |
3.485800E-01 |
|
|
